English
Regional settings| Spread | 0.07 | ||||
 Long position overnight feeLong position overnight fee
Trade size with leverage ~ $5,000.00 Short position overnight fee ~ $4,000.00 | -0.026179% | ||||
| Short position overnight fee Short position overnight fee
Trade size with leverage ~ $5,000.00 Short position overnight fee ~ $4,000.00 | 0.003957% | ||||
| Overnight fee time | 21:00 (UTC) | ||||
| Currency | USD | ||||
| Min traded quantity | 1 | ||||
| Margin | 20 | ||||
| Stock exchange | United States of America | ||||
| Commission on trade1 | 0% |
1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information
| Prev. Close | 10.38 |
| Open | 10.4 |
| 1-Year Change | 170.83% |
| Day's Range | 10.39 - 10.46 |
Tabula Rasa HealthCare, Inc. is a healthcare technology company. It operates through two segments: CareVention HealthCare and MedWise HealthCare. CareVention HealthCare segment provides Programs of All-Inclusive Care (PACE) programs to its clients, with medication fulfillment services, cloud-based software, pharmacy benefit management (PBM) solutions and clinical pharmacist services at the point-of-care. MedWise HealthCare segment provides its clients, primarily health plans and retail pharmacies, with cloud-based software and clinical pharmacy programs. MedWise HealthCare clients include health plans, pharmacies and non-PACE healthcare providers. Services provided to these clients include medication safety services and software subscription solutions. It focuses on the medication safety market and creates solutions designed to enable pharmacists, providers and patients to optimize medication regimens. Its MedWise technology, identifies the cause of medication-related problems.
BRIEF: For the fiscal year ended 31 December 2021, Tabula Rasa HealthCare Inc revenues increased 11% to $331.3M. Net loss decreased 2% to $79.1M. Revenues reflect CareVention HealthCare segment increase of 20% to $248M. Lower net loss reflects Interest Expense - Balancing value decrease of 56% to $9.1M (expense), Intangible asset Impairment charge decrease from $5M (expense) to $0K.
